1 00:00:02,520 --> 00:00:08,720 Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The. 2 00:00:08,720 --> 00:00:12,560 Speaker 2: Stock Movers Report, your roundup of companies making moves in 3 00:00:12,600 --> 00:00:15,880 Speaker 2: the stock market, harnessing the power of Bloomberg Data. 4 00:00:17,120 --> 00:00:18,599 Speaker 1: Let's take a look at some of the stocks on 5 00:00:18,640 --> 00:00:21,840 Speaker 1: the move today on Paul Swenya alongside Alexis Christopherus and 6 00:00:21,880 --> 00:00:24,239 Speaker 1: we're joined by Bloomberg's Christina. You know, Christine, what are 7 00:00:24,239 --> 00:00:26,160 Speaker 1: you looking at today? Well, well, let's talk about in 8 00:00:26,280 --> 00:00:29,040 Speaker 1: Video because that is the one stock that is on 9 00:00:29,120 --> 00:00:33,319 Speaker 1: everybody's minds this morning. So ticker NVDA. Those shares are 10 00:00:33,320 --> 00:00:35,519 Speaker 1: down more than two percent, two and a half percent 11 00:00:35,600 --> 00:00:38,440 Speaker 1: at the moment, actually, and that is because we did 12 00:00:38,440 --> 00:00:42,240 Speaker 1: get that reporting from the Financial Times saying that China's 13 00:00:42,240 --> 00:00:45,720 Speaker 1: Internet regulator has told the country's biggest technology companies to 14 00:00:45,760 --> 00:00:50,840 Speaker 1: stop buying in Vidia chips, specifically the rtx pro six 15 00:00:50,920 --> 00:00:54,440 Speaker 1: thousand D chips. Now, this chip isn't regarded as among 16 00:00:54,520 --> 00:00:57,120 Speaker 1: in Vidia's marquee products. It's more of a high end card. 17 00:00:57,440 --> 00:01:01,120 Speaker 1: They designed it specifically for the restricted Chinese market. But 18 00:01:01,240 --> 00:01:05,360 Speaker 1: now we have this order from the Chinese authorities telling 19 00:01:05,520 --> 00:01:08,320 Speaker 1: their biggest companies to not buy the jit We did 20 00:01:08,400 --> 00:01:12,200 Speaker 1: get a report from the BBC quoting and Viga CEO 21 00:01:12,360 --> 00:01:16,280 Speaker 1: Jensen Huang saying that he's quote disappointed by the ruling 22 00:01:16,360 --> 00:01:18,760 Speaker 1: and that he would be quote patients in responding to 23 00:01:18,800 --> 00:01:22,680 Speaker 1: it right. Also, Christine, General Mills, I guess benefiting from 24 00:01:22,800 --> 00:01:25,399 Speaker 1: the fact that more folks are eating at home, they're 25 00:01:25,440 --> 00:01:26,160 Speaker 1: eating out less. 26 00:01:26,200 --> 00:01:27,920 Speaker 2: But I'm looking at the stock, it's not doing much 27 00:01:27,959 --> 00:01:28,720 Speaker 2: of anything right now. 28 00:01:28,800 --> 00:01:32,800 Speaker 1: Yeah, absolutely, Alexi sits down, So ticker gis General Mills 29 00:01:33,080 --> 00:01:36,679 Speaker 1: shares down just a tenth of one percent at the moment. 30 00:01:36,760 --> 00:01:41,160 Speaker 1: So clearly the first quarter adjusted EPs beat not doing 31 00:01:41,400 --> 00:01:43,440 Speaker 1: much to lift that stock at the moment, but they 32 00:01:43,480 --> 00:01:46,880 Speaker 1: did get that beat. It's eighty six cents topping analyst estimates. 33 00:01:46,880 --> 00:01:50,680 Speaker 1: In the company was saying that is indeed the rise 34 00:01:50,720 --> 00:01:54,520 Speaker 1: of home cooking among value conscious consumers that are struggling 35 00:01:54,520 --> 00:01:57,400 Speaker 1: with inflation. That has helped some of their segments, including 36 00:01:57,480 --> 00:01:59,880 Speaker 1: rice and beans. But at the same time, there is 37 00:02:00,120 --> 00:02:02,080 Speaker 1: kind of a warning in there. They did say that 38 00:02:02,200 --> 00:02:06,160 Speaker 1: sales in North America retail segment dropped thirteen percent for 39 00:02:06,240 --> 00:02:08,640 Speaker 1: the quarter to two point six billion, So that's probably 40 00:02:08,680 --> 00:02:13,120 Speaker 1: people substituting in store brands for name brands. 41 00:02:13,360 --> 00:02:15,320 Speaker 2: I know, I am I know, I am and I 42 00:02:15,360 --> 00:02:17,400 Speaker 2: am all of that the last four or five years. 43 00:02:17,600 --> 00:02:20,320 Speaker 1: Yeah, So that's probably why we're not getting much of 44 00:02:20,320 --> 00:02:22,080 Speaker 1: a lift because there is it's a bit of a 45 00:02:22,200 --> 00:02:25,360 Speaker 1: double edged sword kind of report from General Mills today. 46 00:02:25,480 --> 00:02:29,640 Speaker 1: You spend generations building up brand value and then puff gone. 47 00:02:30,400 --> 00:02:32,040 Speaker 1: That's what a little inflation will take. That's what a 48 00:02:32,080 --> 00:02:35,320 Speaker 1: little inflation to do. L l y Eli Lilly, l 49 00:02:35,600 --> 00:02:38,519 Speaker 1: y Eli Lilly. So those shares not up by much, 50 00:02:38,760 --> 00:02:41,200 Speaker 1: just about to four tens of one percent at the moment. 51 00:02:41,280 --> 00:02:44,000 Speaker 1: But they did get good news from a trial of 52 00:02:44,040 --> 00:02:49,080 Speaker 1: their golp one drug. It's an oral drug, experimental diabetes pill, 53 00:02:49,440 --> 00:02:53,760 Speaker 1: which showed that people on this for the trial lost 54 00:02:53,800 --> 00:02:56,639 Speaker 1: more weight and had a better blood sugar control than 55 00:02:56,840 --> 00:03:00,200 Speaker 1: those in an older approved rival from Novo Nordisk. So 56 00:03:00,280 --> 00:03:02,880 Speaker 1: this is a head to it drug trial. Patients that 57 00:03:02,919 --> 00:03:06,360 Speaker 1: were given Eli Lilly's oral drug lost eight point two 58 00:03:06,360 --> 00:03:09,200 Speaker 1: percent of their body weight in fifty two weeks versus 59 00:03:09,200 --> 00:03:12,640 Speaker 1: five point three percent for the Novo drug. So doctors 60 00:03:12,639 --> 00:03:14,959 Speaker 1: who were kind of they presented the results of doctors 61 00:03:15,000 --> 00:03:18,240 Speaker 1: and the doctors saying that the results look positive. They 62 00:03:18,240 --> 00:03:20,440 Speaker 1: say that the tablet will make it possible to treat 63 00:03:20,480 --> 00:03:23,119 Speaker 1: more patients because it's easier to produce and to take 64 00:03:23,280 --> 00:03:24,600 Speaker 1: given that it is an oral drug. 65 00:03:25,960 --> 00:03:30,000 Speaker 2: The Stock Mover's report from Bloomberg Radio. Check back with 66 00:03:30,080 --> 00:03:32,639 Speaker 2: us throughout the day for the latest roundup of companies 67 00:03:32,720 --> 00:03:35,800 Speaker 2: making news on Wall Street and for the latest market 68 00:03:35,840 --> 00:03:40,320 Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, 69 00:03:40,400 --> 00:03:43,920 Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with 70 00:03:43,960 --> 00:03:45,480 Speaker 2: the Bloomberg Business app.